Sun Pharma Advanced Research Company Ltd share price logo

Sun Pharma Advanced Research Company Ltd Share Price

(SPARC)

Small Cap

Healthcare Sector

₹151.99▲1.37%

as on 11:43AM, 21 Apr 2025

bell
The current prices are delayed by 15 mins, login to check live prices.

Sparc Performance

  • Day's Low

    Day's High

    ₹150.65
    Day's Price Range
    ₹153.22

  • 52 Week's Low

    52 Week's High

    ₹109.3
    52-Week Price Range
    ₹368.45
1 Month Return+ 1.46 %
3 Month Return-15.3 %
1 Year Return-52.55 %
Previous Close₹149.93
Open₹151.99
Volume2.39L
Upper Circuit₹179.91
Lower Circuit₹119.94
Market Cap₹4,865.55Cr

Sparc Fundamentals

P/E Ratio

-12.52

PEG Ratio

16.47

Market Cap

₹4,865.55 Cr

P/B Ratio

96.09

EPS

-11.93

Dividend Yield

0

Sector

Pharmaceuticals

ROE

0

Key events for Sun Pharma Advanced Research Company Ltd

  • SPARC Submits IND Application for Cancer Treatment - 31 Mar, 2025

    Sun Pharma Advanced Research Company (SPARC) has submitted an IND application to the US FDA for its antibody-drug conjugate, SBO-154, marking a significant milestone in cancer treatment development.

Insights on Sun Pharma Advanced Research Company Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 2.15% to 2.23% in Dec 2024 quarter

  • imgPOSITIVE IMPACT

    MF Holding Up

    img

    Mutual Funds have increased holdings from 0.10% to 0.51% in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Divis Laboratories Ltd has given 50.9% return, outperforming this stock by 103.5%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 65.67% of holdings in Dec 2024 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 130.0% return, outperforming this stock by 176.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 year, SPARC stock has moved down by -52.6%

  • imgNEGATIVE IMPACT

    Retail Holding Down

    img

    Retail Investor have decreased holdings from 31.95% to 31.46% in Dec 2024 quarter

Sparc Financials

Value in ₹ crore
DetailsQ'4 23Q'1 24Q'2 24Q'3 24Q'4 24
Revenue₹13.86Cr (-)₹16.56Cr (↑19.48%)₹16.81Cr (↑1.51%)₹12.86Cr (↓23.50%)₹14.91Cr (↑15.94%)
Net Income-₹99.65Cr (-)-₹105.79Cr (↑6.16%)-₹95.90Cr (↓9.35%)-₹107.33Cr (↑11.92%)-₹79.51Cr (↓25.92%)
Net Profit Margin-718.98% (-)-638.83% (↓11.15%)-570.49% (↓10.70%)-834.60% (↑46.30%)-533.27% (↓36.10%)
Value in ₹ crore
Details2021202220232024
Total Assets₹229.70Cr (-)₹280.08Cr (↑21.93%)₹830.12Cr (↑196.39%)₹486.34Cr (↓41.41%)
Total Liabilities₹397.95Cr (-)₹248.85Cr (↓37.47%)₹317.35Cr (↑27.53%)₹361.49Cr (↑13.91%)
Value in ₹ crore
Details20202021202220232024
Operating Cash Flow-₹210.81Cr (-)-₹151.90Cr (↓27.94%)-₹208.23Cr (↑37.08%)-₹69.12Cr (↓66.81%)-₹429.43Cr (↑521.28%)

Sparc Index Inclusions

S&P BSE 250 SmallCap

₹6,267.83

1.48 (▲91.54%)

BSE 500

₹34,552.88

1.3 (▲443.21%)

BSE Healthcare

₹41,842.29

0.35 (▲145.17%)

S&P BSE 400 MidSmallCap

₹11,132.39

1.63 (▲178.88%)

S&P BSE AllCap

₹10,471.31

0.68 (▲71.07%)

BSE Small-Cap

₹48,578.44

1.32 (▲631.78%)

Sparc Shareholding Pattern

InvestorsHoldings %FY Quarter3M change
Promoter Holdings
65.67%
0.00
Foreign Institutions
2.23%
3.79
Mutual Funds
0.51%
388.02
Retail Investors
31.46%
-1.53
Others
0.13%
4.48

Sparc Key Indicators

Details2024
Return On Assets %-79.62
Details2024
Book Value Per Share (₹)3.88
Details2024
Earning Per Share (₹)-11.93

Sparc Valuation

Sparc in the last 5 years

  • Overview

  • Trends

Lowest (-38.16x)

April 8, 2024

Today (-12.52x)

April 17, 2025

Industry (53.02x)

April 17, 2025

Highest (0.00x)

December 29, 2023

LowHigh

Sparc Earnings and Dividends

  • Sun Pharma Advanced Research Company Ltd Earnings Results

    Sun Pharma Advanced Research Company Ltd’s net profit jumped 20.21% since last year same period to ₹-79.51Cr in the Q3 2024-2025. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 25.92% jump in its net profits since last 3-months.

    Read More about Earnings Results

Sparc Technicals Summary

Bearish

Neutral

Bullish

Bullish

Sun Pharma Advanced Research Company Ltd is currently in a Bullish trading position according to technical analysis indicators.

More on Technical Analysis

Sparc Peer Comparison

Company
Analyst ViewMarket Cap5 Year CAGRDebt to Asset RatioNet ProfitYearly Revenue
Sun Pharma Advanced Research Company Ltd
Sun Pharma Advanced Research Company Ltd
NA₹4,865.55 Cr1.46%0.79-₹388 Cr₹75 Cr
Suven Pharmaceuticals Ltd
Suven Pharmaceuticals Ltd
BUY₹29,735.73 Cr147.53%0.52₹300 Cr₹1,051 Cr
Jubilant Pharmova Ltd
Jubilant Pharmova Ltd
BUY₹14,638.87 Cr40.19%0.57₹72 Cr₹6,702 Cr
Rainbow Childrens Medicare Ltd
Rainbow Childrens Medicare Ltd
BUY₹15,265.25 Cr46.78%0.68₹218 Cr₹1,296 Cr
Poly Medicure Ltd
Poly Medicure Ltd
BUY₹24,252.31 Cr186.65%0.55₹258 Cr₹1,375 Cr
See all

About Sparc

Sun Pharma Advanced Research Company Ltd (“SPARC”) is a clinical stage biopharmaceutical company focused on innovation and new product development for global markets. Established in 2006, it is engaged in the creation of new drugs and delivery systems, undertaking projects in research and technology for new chemical entities (“NCEs”) and novel drug delivery systems (“NDDS”). SPARC operates in global markets including the US, India and China. It has successfully received approvals from the US FDA for various drugs such as ELEPSIA XR Levetiracetam extended-release tablets 1000 mg and 1500 mg, XELPROS Latanoprost BAKfree eyedrops and for XELPROS latanoprost ophthalmic emulsion 0.005 which was inlicensed from Sun Pharma in 2015. In 2021, it commenced the commercialization of ElepsiaTM XR to Visiox Pharma, with eligible milestone payments and royalties and acquired exclusive rights for antibody against a unique oncology target from Biomodifying. SPARC is focused on advancement of clinical trials with vodobatinib being granted orphan drug designation for the treatment of CML and it has completed phase I study of SCD044.

Revenue: ₹14.91Cr as on December 2024 (Q4 24)
Net Profit: ₹-79.51Cr as on December 2024 (Q4 24)
Listing date: 18 Jul, 2007
Chairperson Name: Dilip S Shanghvi
OrganisationSparc
HeadquartersMumbai
IndustryPharmaceuticals
E-voting on sharesClick here to vote

FAQs on Sun Pharma Advanced Research Company Ltd

What is Sun Pharma Advanced Research Company Ltd price today?

Sun Pharma Advanced Research Company Ltd share price today stands at ₹151.99, Open: ₹151.99, Previous Close: ₹149.93, High: ₹153.22, Low: ₹150.65, 52 Week High: ₹368.45, 52 Week Low: ₹109.3.

How to Buy Sun Pharma Advanced Research Company Ltd Share in India?

  • Get a PAN card
  • Open a Demat account
  • Open a Trading account
  • Link your Demat account to your Trading account
  • Fund your Trading account
  • Place an order to buy Sun Pharma Advanced Research Company Ltd shares

What are today's traded volumes of Sun Pharma Advanced Research Company Ltd?

Today's traded volume of Sun Pharma Advanced Research Company Ltd(SPARC) is 2.39L.

What is today's market capitalisation of Sun Pharma Advanced Research Company Ltd?

Today's market capitalisation of Sun Pharma Advanced Research Company Ltd(SPARC) is ₹4865.55Cr.

What is the 52 Week High and Low Range of Sun Pharma Advanced Research Company Ltd?

Sun Pharma Advanced Research Company Ltd (SPARC)
Price
52 Week High
₹368.45
52 Week Low
₹109.3

How much percentage Sun Pharma Advanced Research Company Ltd is down from its 52 Week High?

Sun Pharma Advanced Research Company Ltd (SPARC) share price is ₹151.99. It is down -58.75% from its 52 Week High price of ₹368.45

How much percentage Sun Pharma Advanced Research Company Ltd is up from its 52 Week low?

Sun Pharma Advanced Research Company Ltd (SPARC) share price is ₹151.99. It is up 39.06% from its 52 Week Low price of ₹109.3